CureSHANK (@CureSHANK) header
CureSHANK (@CureSHANK) profile picture

Relentlessly focused on turning science into life-transforming therapies for #phelanmcdermidsyndrome.

Los Angeles, CA
Joined June 2019
Photo by CureSHANK (@CureSHANK)Photo by CureSHANK (@CureSHANK)Photo by CureSHANK (@CureSHANK)Photo by CureSHANK (@CureSHANK)Photo by CureSHANK (@CureSHANK)Photo by CureSHANK (@CureSHANK)Photo by CureSHANK (@CureSHANK)Photo by CureSHANK (@CureSHANK)Photo by CureSHANK (@CureSHANK)Photo by CureSHANK (@CureSHANK)
Jenny’s daughter, Avery Grace, was diagnosed with Phelan-McDermid syndrome at age 10 after a challenging diagnostic journey. After participating in CureSHANK’s Externally Led Patient Focused Drug Development meeting, Jenny wanted to deepen her involvement in the early research that can drive PMS drug development. Jenny joined the CureSHANK Board of Directors to be part of the community to accelerate life-transforming therapies for PMS. “Phelan-McDermid syndrome has been devastating for Avery and our family. If there’s a way that I can help move us closer to treatments for her and others like her, I want to be a part of it.” We are thankful to have Jenny on our Board of Directors and for her playing such an active role in bringing PMS therapies within reach for families. It takes all of our community to advance therapies for PMS. When you donate today, every gift is matched dollar for dollar, so your support goes twice as far. Double your impact at cureshank.org/give #PhelanMcDermidSyndrome #CureSHANK #BoardOfDirectors #PMSFamilies @jagraham1978
1
1
45
Meet CureSHANK Board Member Jarid Richards 💙 This week, we’re introducing you to a couple of the incredible individuals from the CureSHANK Board of Directors. Each Board Member has a close personal connection to Phelan-McDermid syndrome and brings valuable insight and skills to help us advance our mission. Jarid’s nephew, Daxton, was diagnosed with Phelan-McDermid syndrome at a very young age. Daxton passed away in 2023, at age seven, from complications related to PMS. Jarid was drawn to CureSHANK to be part of the mission to bring life-transforming therapies for PMS within reach, to support his sister and family and to honor the memory of Daxton. We are thankful to have Jarid on our Board of Directors and for his commitment to helping other families affected by Phelan-McDermid syndrome in Daxton’s memory. #PhelanMcDermidSyndrome #CureSHANK #BoardOfDirectors #PMSFamilies
47
Research is our best hope for advancing treatments and eventually finding a cure for Phelan McDermid syndrome. Right now, there are several clinical trials and research studies actively recruiting PMS patients and caregivers. Swipe to check out all the opportunities that are actively recruiting. CureSHANK is at the forefront of Phelan-McDermid syndrome research and treatment development. Check back here for the latest updates on active trials and studies. 🔗 To learn more about these studies and how you can enroll in them, visit cureshank.org/participate-in… #PMSResearch #PhelanMcDermidSyndrome #ClinicalTrials #ResearchStudies #PMSTreatments
1
1
62
Meet CureSHANK Board Member Jenny Graham Beeson and her daughter Avery 💙 This week, we’re introducing you to a couple of the incredible individuals from the CureSHANK Board of Directors. Each Board Member has a close personal connection to Phelan-McDermid syndrome and brings valuable insight and skills to help us advance our mission. Jenny’s 20 year old daughter, Avery, is living with Phelan-McDermid syndrome. In this video, Jenny shares the love and light of Avery and the daily challenges their family faces. Jenny joined the CureSHANK Board of Directors to help Avery and to be part of an organization whose sole mission is to find treatments for Phelan-McDermid syndrome. “In supporting CureSHANK…you’re supporting my child. You’re supporting the possibility that her life could be a little bit better. And that means everything to me.” Give today and support families like Avery’s. Double your impact at cureshank.org/give @jagraham1978 #CureSHANK #PhelanMcDermidSyndrome #PMSResearch #GivingSeason
49
Joanna shares a simple but powerful wish that captures the PMS family experience: to feel like a parent, not just a caregiver, would be extremely meaningful. More than anything, parents of children living with PMS want their child to be safe and cared for. It’s what drives our advocacy for more effective therapies for all loved ones with PMS. A better future for PMS families is within reach. Together, we can accelerate life-transforming therapies for Phelan-McDermid syndrome. Be part of the community making it happen. Give today and double your impact: cureshank.org/give This week, in honor of World Kindness Day, we’ve shared what would make the most meaningful difference for families affected by PMS. Check out other videos posted this week to hear what other parents shared. #PhelanMcDermidSyndrome #PMSResearch #CureSHANK #PMSCaregivers #WorldKindnessDay
1
1
48
Like other moms indicated this week, Courtney shares that improved communication would make a meaningful difference for her and her family. This aligns with insights that CureSHANK gathered in the Voice of the Patient Report, where communication issues were listed as one of the most impactful PMS-related health concerns. The heart of CureSHANK’s work is the families. As we continue to share PMS family perspectives, we are ensuring that the experiences, needs, and priorities of people living with PMS shape the development of new treatments. Give today and support our continued work to share PMS family voices with the scientific community: cureshank.org/give This week, in honor of World Kindness Day, we’re sharing what would make the most meaningful difference for families affected by PMS. Check out other videos posted this week to hear what other parents shared. @pmsshank3mama #PhelanMcDermidSyndrome #PMSResearch #CureSHANK #PMSCaregivers #WorldKindnessDay
28
Meagen’s wish about what would make the most meaningful difference for her family is a great message for World Kindness Day today. She encourages people who meet Gus to ask questions and approach with more understanding. Like other PMS moms who shared this week, she also wishes for a cure and expresses what so many families feel: even small improvements would make a world of difference for their child’s quality of life. 2026 was a year of historic milestones for the advancement of PMS science and treatments. We plan to use that momentum to make significant strides in our mission in 2027. Be part of the community making it happen. Give today and double your impact: cureshank.org/give This week, in honor of World Kindness Day, we’re sharing what would make the most meaningful difference for families affected by PMS. Stay tuned to hear from more PMS parents through the weekend! #PhelanMcDermidSyndrome #PMSResearch #CureSHANK #PMSCaregivers #WorldKindnessDay
28
November 13th is World Kindness Day! Today we’re asking for our community to join us in recognizing World Kindness Day by taking a kind action! Here’s a few ideas to get you started: 🔹Thank a community figure for their support 🔹Call or connect with another PMS parent 🔹Share a resource with the PMS community 🔹Raise awareness for PMS 🔹Advocate for meaningful treatments 🔹Donate to CureSHANK at cureshank.org/give 🔹And more! We’ll start things off by expressing our gratitude for the CureSHANK community. Thank you to all of our partners, researchers, fellow parents, and advocates for helping us to accelerate life-transforming therapies for Phelan-McDermid syndrome. We could not do this without you. Spread some kindness 💙 #WorldKindnessDay #PhelanMcDermidSyndrome #PMSResearch #CureSHANK
21
Legislative Update: National Plan for Epilepsy Act The National Plan for Epilepsy Act has advanced through the U.S. Senate and remains under consideration in Congress. The legislation focuses on strengthening national coordination around epilepsy research, care, and public health. These issues are relevant to individuals and families affected by rare neurodevelopmental disorders, including Phelan-McDermid syndrome. Epilepsy occurs in about one-third of individuals with PMS. At CureSHANK, we recognize the importance of continued research, collaboration, and awareness of policies affecting our community. We encourage families and advocates to learn more about the legislation, stay informed about legislative developments, and, if interested, connect with their members of Congress to share their experiences and perspectives on epilepsy research and care. To look up your legislator, visit bit.ly/NP4E @EpilepsyFdn #RareDisease #Epilepsy #PhelanMcDermidSyndrome #EpilepsyAwarenessMonth
23
📝 Participate in Active Clinical Research Study Testing a Novel Device to Study Sleep at Home in Children with Profound Autism The purpose of this study is to validate the use of a wearable, at-home EEG device to measure sleep in individuals with profound autism/cognitive impairment. This population has been historically excluded from autism sleep research due to challenges with the lab setting, despite interrupted sleep being a frequently reported challenge. Study Type: Research study Age Range: 12-19 years old Location: Boston, MA + Remote Option Eligibility criteria: Individuals with a Phelan-McDermid syndrome diagnosis that struggle with interrupted sleep. It is not necessary for participants to have an autism diagnosis. Participants may be diagnosed with seizures, but seizures must be currently controlled. Participants may not have additional neurological disorders besides PMS. Contact the study coordinator at mghluriecentersleepheadbandstudy[at]mgb[dot]org for details and participation information. For more info: buff.ly/q2foNFj #PhelanMcDermidSyndrome #SleepStudy #CureSHANK #ParticipateInResearch #MGHLurie
32
Earlier this week, Paige and Brooke shared what would make a meaningful difference for their families: having a cure and the ability to communicate. Martha feels the same. She also shared openly about the daily impact of Phelan-McDermid syndrome on her son Matthew and the entire family. It takes a community. Join the global effort to accelerate life-transforming therapies for families like Matthew’s. For a limited time, every gift will be doubled thanks to a generous matching donor. Double your gift at cureshank.org/give In honor of World Kindness Day tomorrow, we’re sharing what would make the most meaningful difference for families affected by PMS. Stay tuned to hear from more PMS parents through the weekend! #PhelanMcDermidSyndrome #PMSResearch #CureSHANK #PMSCaregivers #WorldKindnessDay
51
November is National Epilepsy Awareness Month 💜 Epilepsy occurs in about one-third of individuals with Phelan-McDermid syndrome, making it a common feature of PMS. With approximately 45,000 Americans living with PMS, that means an estimated 15,000 Americans have SHANK3-related epilepsy. The overall population of Americans living with SHANK3-related epilepsy is comparable to (or may exceed) that of individuals living with other genetic disorders such as Rett syndrome, Angelman syndrome, or Dravet syndrome. Some individuals with PMS can develop Lennox-Gastaut syndrome, which is characterized by multiple seizure types, slow spike-and-wave bursts, and treatment-resistant epilepsy. Join us in recognizing National Epilepsy Awareness Month throughout November! This year’s theme is “Where Community Sparks Hope” and highlights the power of community to create greater understanding and connection so every person impacted by epilepsy feels valued and supported. That includes our PMS community. This November, we’re shining a light on how research, drug development, and awareness can accelerate the path to therapies for PMS -- including SHANK3-related epilepsy. Learn more by following @EpilepsyFdn or visiting epilepsy.com #NationalEpilepsyAwarenessMonth #PhelanMcDermidSyndrome #PMSResearch #SHANK3
42
Research Study Update: Marvel’s MB-204 Preclinical Data in Mice Marvel Biosciences, a Canadian biotech company, has announced preliminary data from its preclinical SHANK3 mouse model study conducted at the iBraiN Institute at the University of Tours (France) by Dr. Julie Le Merrer and Dr. Jerome Becker. Marvel’s Chief Science Officer Dr. Mark Williams shared, “We are very pleased with the results, which confirms the efficacy of MB-204 as a potential first and best-in-class treatment for autism. We look forward to testing MB-204 for the first time in patients as we prepare for our Phase 1 clinical trial.” The study evaluated the efficacy of MB-204 in comparison to Istradefylline, a clinically approved drug for the treatment of Parkinson’s Disease. Marvel reports that MB-204 demonstrated broader efficacy than Istradefylline with the ability to normalize multiple disease-associated behavioral abnormalities. While the mouse model is associated with Phelan-McDermid syndrome, Marvel will further investigate the treatment’s efficacy across autism and other neurodevelopmental conditions. Please note that this data is from preclinical mouse studies and MB-204 has yet to be approved for testing in human patients. But for PMS families, it’s one more sign of growing interest in development of therapies for PMS. We look forward to following the further development of this program. Read the press release to learn more and access three video demonstrations from Marvel: buff.ly/dZcgZMC #PhelanMcDermidSyndrome #PMSResearch #AutismResearch #NeurodevelopmentalConditions #MarvelBiosciences
53
❗️REMINDER❗ Help Advance Research in Phelan-McDermid Syndrome - Milestone Survey Caregivers of individuals with Phelan-McDermid syndrome (PMS) are invited to participate in an online research study of developmental milestones. This research study aims to better understand how developmental milestones, or skills, change over time in individuals living with PMS. Understanding how skills are gained, lost, or regained helps researchers better understand PMS. The input from this study may help inform further research and potential treatments in the future. Fully Remote Participation. All study activities take place online. Surveys can be completed from home and saved to finish later at your convenience. You May Qualify If: ☑️ You are an adult and are a caregiver of someone with Phelan-McDermid syndrome ☑️ You are willing to complete an online survey at three time points over the next 12 months ☑️ You are willing to share developmental milestone information and documentation when available ☑️ Your loved one is between ages 2 and 30 ☑️ You can complete surveys in English Final eligibility will be determined by the study team based on study requirements. Learn more about the study and check your eligibility: bit.ly/4dk3isC #PhelanMcDermidSyndrome #ResearchOpportunity #CaregiverResearch #ParticipateInResearch #PatientAdvocacy
42
Brooke and her husband have tried every tool possible to communicate with their daughter, Belle. Because Belle cannot tell them how she feels, what she needs, or where it hurts, they’re often left to guess. In the case of Belle’s celiac disease, it took them six months to finally know the cause of their daughter’s pain. Stories like Brooke’s matter. When researchers grasp the daily heartbreak of not being able to communicate with your own child, they understand what’s at stake. That’s why we uplift PMS community voices as we work to advance life-transforming therapies for PMS. Help us make a meaningful difference for PMS families like Belle’s. Every gift made for a limited time will be doubled, thanks to a generous matching donor. Double your gift at cureshank.org/give In honor of World Kindness Day on November 13th, we’re sharing what would make the most meaningful difference for families affected by PMS. Stay tuned to hear from more PMS parents throughout the week! #PhelanMcDermidSyndrome #PMSResearch #CureSHANK #PMSCaregivers #WorldKindnessDay
62
What would make the most meaningful difference for Paige and her family? Watch the clip to find out! Paige’s wish for more advocacy and progress for meaningful PMS treatments resonates deeply with us. That’s why we work every day to advance PMS research and treatments. It’s also why we’re uplifting PMS community voices. Individuals like Paige remind us of the “why” behind the research and treatment development. In honor of World Kindness Day on November 13th, we’re sharing what would make the most meaningful difference for families affected by PMS. Stay tuned to hear from more PMS parents throughout the week! Spread kindness by supporting the acceleration of life-transforming therapies for PMS at cureshank.org/give #PhelanMcDermidSyndrome #PMSResearch #CureSHANK #PMSCaregivers #WorldKindnessDay
52
Happy November! This month, in honor of National Family Caregivers, we're uplifting PMS family stories. CureSHANK’s progress is fueled by the voices of our dedication, voices and support of our incredible community. We invite you to be part of the progress ahead. In this month’s edition: 💸 Support CureSHANK’s work to accelerate life-transforming therapies for PMS 📚 Uplift the PMS caregiver voice by listening to some featured PMS parent stories 📊 Insights from our new weekly community poll series 💊 The rise of ASO therapy development and what it means for PMS 📢 Calling PMS families for the Burden of Illness International Study Read this month’s issue: buff.ly/cf0hQe0 If something resonates, share it with your community. Every post helps us reach more PMS families. #PhelanMcDermidSyndrome #PMSResearch #NationalFamilyCaregiversMonth #CaregiverStories
27
Meet Brooke and her daughter, Belle 💙 When her daughter’s care team downplayed Brooke’s concerns and told her to be patient, Brooke trusted her “mom gut” and kept seeking answers for Belle’s developmental delays. After Belle’s first birthday, they received an answer: Belle was diagnosed with Phelan-McDermid syndrome. Stories like Belle’s highlight how parents go above and beyond for their children. It also emphasizes the importance of a care team that matches a family's urgency, pursues early testing, and connects them with the right specialists. For National Family Caregivers Month, we’re uplifting the voices of PMS parents and caregivers. By sharing their stories, we will ensure that the PMS family voice is connected to research and treatment development. Join us as we work to ensure patient and caregiver voices are included in every aspect of PMS research and treatment. Donate today at cureshank.org/give2026 #PMSCaregivers #NationalFamilyCaregiversMonth #PhelanMcDermidSyndrome #PMSResearch
1
70
Meet Martha and her son, Matthew 💙 Thanks to PMS warrior moms (like Martha) and dads, CureSHANK has had the community support to help advance PMS research and treatments. Today, we’re honored to introduce you to Martha and her son, Matthew. In honor of National Family Caregivers Month, we’re uplifting the voices of PMS parents and caregivers. By sharing their stories, we will ensure that the PMS family voice is connected to research and treatment development. As PMS research and treatment development progresses, be part of the movement to ensure patient and caregiver voices are included every step of the way. Donate today at cureshank.org/Give2026 #PMSCaregivers #NationalFamilyCaregiversMonth #PhelanMcDermidSyndrome #PMSResearch
48